Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

Background: Among patients with non-small cell lung cancer (NSCLC), the impact of first-line treatment on overall survival (OS) may be influenced by subsequent therapies. Thus, using patient-level data, we assessed the relationships of progression-free survival (PFS) and post-progression survival (P...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncology 2021-08, Vol.99 (9), p.562-570
Hauptverfasser:	Imai, Hisao, Kishikawa, Takayuki, Minemura, Hiroyuki, Yamada, Yutaka, Ibe, Tatsuya, Mori, Keita, Yamaguchi, Ou, Mouri, Atsuto, Hamamoto, Yoichiro, Kanazawa, Kenya, Kasai, Takashi, Kaira, Kyoichi, Kaburagi, Takayuki, Minato, Koichi, Kobayashi, Kunihiko, Kagamu, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Study Development and progression Lung cancer, Non-small cell Patient outcomes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!